Apyx Historical Balance Sheet

APYX Stock

USD 1.35 0.09 7.14%

Trend analysis of Apyx Medical balance sheet accounts such as Short Long Term Debt Total of 4.1 M, Other Current Liabilities of 8.1 M or Total Current Liabilities of 11.3 M provides information on Apyx Medical's total assets, liabilities, and equity, which is the actual value of Apyx Medical to its prevalent stockholders. By breaking down trends over time using Apyx Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Apyx Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Apyx Medical is a good buy for the upcoming year.

Apyx Medical Inventory

5.41 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

About Apyx Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Apyx Medical at a specified time, usually calculated after every quarter, six months, or one year. Apyx Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Apyx Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Apyx currently owns. An asset can also be divided into two categories, current and non-current.

Apyx Medical Balance Sheet Chart

At this time, Apyx Medical's Total Current Assets are fairly stable compared to the past year. Long Term Debt is likely to rise to about 35.6 M in 2025, whereas Total Assets are likely to drop slightly above 34.2 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Inventory

Add Fundamental

Total Assets

Total assets refers to the total amount of Apyx Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Apyx Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Apyx Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Apyx Medical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Apyx Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Apyx Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.At this time, Apyx Medical's Total Current Assets are fairly stable compared to the past year. Long Term Debt is likely to rise to about 35.6 M in 2025, whereas Total Assets are likely to drop slightly above 34.2 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	796K	38.5M	4.9M	4.1M
Total Assets	51.8M	79.2M	64.8M	34.2M

Short Long Term Debt Total Total Assets

Apyx Medical balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.12	0.49	0.74	0.83	0.44	0.28	-0.66	0.21	0.64	0.75	-0.09	0.24	0.91	0.57	-0.31	0.04	0.83	0.1	0.19	0.74	0.57	0.27	0.52	0.95	0.64
Short Long Term Debt Total	0.12		0.11	0.15	-0.29	0.18	-0.24	0.31	-0.39	0.28	0.2	0.2	0.39	0.04	0.02	-0.11	-0.14	0.05	0.59	0.37	0.16	0.17	0.56	0.51	0.08	-0.18
Other Current Liab	0.49	0.11		0.81	0.27	0.16	-0.11	-0.23	-0.44	0.73	0.36	-0.24	0.58	0.34	0.86	-0.23	0.22	0.65	0.34	0.42	0.49	0.78	0.5	0.34	0.57	0.49
Total Current Liabilities	0.74	0.15	0.81		0.49	0.28	0.07	-0.67	-0.32	0.86	0.81	-0.23	0.56	0.64	0.9	-0.31	0.2	0.77	0.39	0.25	0.77	0.84	0.58	0.45	0.82	0.57
Total Stockholder Equity	0.83	-0.29	0.27	0.49		0.32	0.47	-0.66	0.6	0.28	0.54	-0.13	-0.12	0.83	0.36	-0.33	0.05	0.64	-0.35	-0.04	0.57	0.27	-0.19	0.1	0.8	0.65
Property Plant And Equipment Net	0.44	0.18	0.16	0.28	0.32		0.23	-0.26	0.01	0.4	0.32	0.76	0.29	0.16	0.29	-0.73	-0.73	0.6	0.03	0.71	0.48	0.33	0.09	0.79	0.29	0.33
Current Deferred Revenue	0.28	-0.24	-0.11	0.07	0.47	0.23		-0.34	0.45	0.09	0.15	-0.13	-0.6	0.3	-0.08	-0.24	-0.06	0.38	-0.46	-0.29	-0.02	-0.03	-0.39	-0.08	0.2	0.18
Net Debt	-0.66	0.31	-0.23	-0.67	-0.66	-0.26	-0.34		-0.12	-0.45	-0.85	0.19	-0.14	-0.67	-0.58	0.24	-0.1	-0.58	-0.02	0.23	-0.69	-0.47	-0.18	-0.2	-0.71	-0.57
Retained Earnings	0.21	-0.39	-0.44	-0.32	0.6	0.01	0.45	-0.12		-0.36	-0.12	-0.05	-0.68	0.25	-0.4	0.12	0.06	-0.09	-0.84	-0.31	0.03	-0.61	-0.82	-0.38	0.06	0.21
Accounts Payable	0.64	0.28	0.73	0.86	0.28	0.4	0.09	-0.45	-0.36		0.61	-0.11	0.47	0.4	0.74	-0.13	0.16	0.76	0.32	0.45	0.71	0.68	0.49	0.63	0.59	0.45
Cash	0.75	0.2	0.36	0.81	0.54	0.32	0.15	-0.85	-0.12	0.61		-0.12	0.41	0.73	0.65	-0.3	0.09	0.65	0.36	-0.02	0.79	0.64	0.51	0.46	0.81	0.52
Non Current Assets Total	-0.09	0.2	-0.24	-0.23	-0.13	0.76	-0.13	0.19	-0.05	-0.11	-0.12		0.26	-0.28	-0.12	-0.62	-0.91	0.02	0.08	0.67	-0.02	-0.03	0.01	0.54	-0.2	-0.14
Non Currrent Assets Other	0.24	0.39	0.58	0.56	-0.12	0.29	-0.6	-0.14	-0.68	0.47	0.41	0.26		0.11	0.69	-0.33	-0.23	0.27	0.76	0.52	0.43	0.67	0.8	0.6	0.35	0.22
Cash And Short Term Investments	0.91	0.04	0.34	0.64	0.83	0.16	0.3	-0.67	0.25	0.4	0.73	-0.28	0.11		0.41	-0.27	0.12	0.65	0.15	-0.12	0.56	0.51	0.28	0.25	0.95	0.52
Net Receivables	0.57	0.02	0.86	0.9	0.36	0.29	-0.08	-0.58	-0.4	0.74	0.65	-0.12	0.69	0.41		-0.31	0.12	0.67	0.36	0.29	0.69	0.8	0.53	0.42	0.66	0.63
Good Will	-0.31	-0.11	-0.23	-0.31	-0.33	-0.73	-0.24	0.24	0.12	-0.13	-0.3	-0.62	-0.33	-0.27	-0.31		0.77	-0.47	-0.22	-0.49	-0.23	-0.51	-0.27	-0.46	-0.37	-0.23
Common Stock Total Equity	0.04	-0.14	0.22	0.2	0.05	-0.73	-0.06	-0.1	0.06	0.16	0.09	-0.91	-0.23	0.12	0.12	0.77		-0.06	-0.16	-0.52	0.08	-0.08	-0.1	-0.49	0.08	0.07
Common Stock Shares Outstanding	0.83	0.05	0.65	0.77	0.64	0.6	0.38	-0.58	-0.09	0.76	0.65	0.02	0.27	0.65	0.67	-0.47	-0.06		0.13	0.39	0.64	0.76	0.3	0.65	0.78	0.57
Non Current Liabilities Total	0.1	0.59	0.34	0.39	-0.35	0.03	-0.46	-0.02	-0.84	0.32	0.36	0.08	0.76	0.15	0.36	-0.22	-0.16	0.13		0.23	0.1	0.65	0.97	0.5	0.26	-0.14
Inventory	0.19	0.37	0.42	0.25	-0.04	0.71	-0.29	0.23	-0.31	0.45	-0.02	0.67	0.52	-0.12	0.29	-0.49	-0.52	0.39	0.23		0.29	0.36	0.26	0.71	0.08	0.08
Other Current Assets	0.74	0.16	0.49	0.77	0.57	0.48	-0.02	-0.69	0.03	0.71	0.79	-0.02	0.43	0.56	0.69	-0.23	0.08	0.64	0.1	0.29		0.47	0.28	0.5	0.7	0.7
Other Stockholder Equity	0.57	0.17	0.78	0.84	0.27	0.33	-0.03	-0.47	-0.61	0.68	0.64	-0.03	0.67	0.51	0.8	-0.51	-0.08	0.76	0.65	0.36	0.47		0.77	0.58	0.7	0.36
Total Liab	0.27	0.56	0.5	0.58	-0.19	0.09	-0.39	-0.18	-0.82	0.49	0.51	0.01	0.8	0.28	0.53	-0.27	-0.1	0.3	0.97	0.26	0.28	0.77		0.55	0.43	0.02
Property Plant And Equipment Gross	0.52	0.51	0.34	0.45	0.1	0.79	-0.08	-0.2	-0.38	0.63	0.46	0.54	0.6	0.25	0.42	-0.46	-0.49	0.65	0.5	0.71	0.5	0.58	0.55		0.4	0.24
Total Current Assets	0.95	0.08	0.57	0.82	0.8	0.29	0.2	-0.71	0.06	0.59	0.81	-0.2	0.35	0.95	0.66	-0.37	0.08	0.78	0.26	0.08	0.7	0.7	0.43	0.4		0.62
Short Term Debt	0.64	-0.18	0.49	0.57	0.65	0.33	0.18	-0.57	0.21	0.45	0.52	-0.14	0.22	0.52	0.63	-0.23	0.07	0.57	-0.14	0.08	0.7	0.36	0.02	0.24	0.62

Click cells to compare fundamentals

Apyx Medical Account Relationship Matchups

Apyx Medical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	74.1M	68.7M	51.8M	79.2M	64.8M	34.2M
Short Long Term Debt Total	676K	305K	796K	38.5M	4.9M	4.1M
Other Current Liab	6.3M	9.6M	13.6M	9.2M	7.8M	8.1M
Total Current Liabilities	9.2M	13.2M	11.9M	12.7M	10.7M	11.3M
Total Stockholder Equity	63.7M	53.7M	37.6M	26.7M	14.2M	24.1M
Property Plant And Equipment Net	7.2M	6.9M	7.6M	7.1M	6.7M	5.4M
Current Deferred Revenue	5.6M	8.4M	853K	488K	439.2K	417.2K
Net Debt	(41.2M)	(30.6M)	(9.4M)	(5.2M)	(26.9M)	(25.5M)
Retained Earnings	2.6M	(12.6M)	(35.7M)	(54.4M)	(77.9M)	(74.0M)
Accounts Payable	1.5M	2.6M	2.7M	2.7M	2.6M	1.3M
Cash	41.9M	30.9M	10.2M	43.7M	31.7M	33.3M
Non Current Assets Total	8.0M	8.0M	8.8M	8.9M	8.4M	8.3M
Non Currrent Assets Other	807K	1.1M	1.2M	1.7M	1.7M	1.7M
Cash And Short Term Investments	41.9M	30.9M	10.2M	43.7M	31.7M	33.3M
Net Receivables	17.3M	21.2M	18.2M	14.1M	15.5M	16.3M
Common Stock Shares Outstanding	34.2M	34.3M	34.5M	34.6M	35.5M	22.9M
Liabilities And Stockholders Equity	74.1M	68.7M	51.8M	79.2M	64.8M	34.2M
Non Current Liabilities Total	1.1M	1.5M	2.1M	39.6M	39.8M	41.8M
Inventory	4.1M	6.8M	11.8M	9.9M	7.6M	5.4M
Other Current Assets	2.8M	1.9M	2.7M	2.7M	1.7M	1.1M
Other Stockholder Equity	61.1M	66.2M	73.3M	81.1M	92.1M	96.7M
Total Liab	10.3M	14.7M	14.0M	52.3M	50.5M	53.0M
Property Plant And Equipment Gross	7.2M	6.9M	7.6M	10.7M	10.7M	5.6M
Total Current Assets	66.1M	60.7M	43.0M	70.4M	56.4M	59.3M
Short Term Debt	728K	574K	506K	367K	355K	322.6K
Other Assets	191K	1.5M	1.1M	1.2M	1.4M	1.1M
Property Plant Equipment	6.6M	7.2M	6.6M	6.8M	7.8M	5.8M
Net Tangible Assets	71.3M	63.7M	53.7M	37.6M	43.2M	40.5M
Retained Earnings Total Equity	14.5M	2.6M	(12.6M)	(35.7M)	(41.1M)	(39.0M)
Capital Surpluse	56.7M	61.1M	66.2M	73.3M	84.3M	51.5M
Non Current Liabilities Other	166K	184K	724K	198K	259K	356.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Apyx Historical Balance Sheet

Apyx Medical Inventory

5.41 Million

About Apyx Balance Sheet Analysis

Apyx Medical Balance Sheet Chart

Total Assets

Total Current Liabilities

Apyx Medical balance sheet Correlations

Apyx Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Apyx Medical balance sheet Accounts

Also Currently Popular

Additional Tools for Apyx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.97	Non Current Liabilities Total
Total Current Assets	+ 0.95	Total Assets
Total Current Assets	+ 0.95	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.91	Total Assets
Net Receivables	+ 0.9	Total Current Liabilities
Net Receivables	+ 0.86	Other Current Liab

Common Stock Total Equity	- 0.91	Non Current Assets Total
Cash	- 0.85	Net Debt
Non Current Liabilities Total	- 0.84	Retained Earnings
Total Liab	- 0.82	Retained Earnings
Common Stock Total Equity	- 0.73	Property Plant And Equipment Net
Good Will	- 0.73	Property Plant And Equipment Net